C-Rad Future Growth
Future criteria checks 5/6
C-Rad is forecast to grow earnings and revenue by 49% and 15.9% per annum respectively. EPS is expected to grow by 49.6% per annum. Return on equity is forecast to be 23% in 3 years.
Key information
49.0%
Earnings growth rate
49.6%
EPS growth rate
Medical Equipment earnings growth | 22.2% |
Revenue growth rate | 15.9% |
Future return on equity | 23.0% |
Analyst coverage | Low |
Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2024 | 431 | 78 | 68 | 78 | 2 |
12/31/2023 | 370 | 54 | 46 | 52 | 2 |
12/31/2022 | 294 | 22 | 23 | 31 | 2 |
6/30/2022 | 260 | 12 | -6 | 1 | N/A |
3/31/2022 | 257 | 21 | 6 | 12 | N/A |
12/31/2021 | 261 | 25 | 12 | 18 | N/A |
9/30/2021 | 258 | 26 | 16 | 23 | N/A |
6/30/2021 | 247 | 25 | 30 | 36 | N/A |
3/31/2021 | 230 | 17 | 26 | 32 | N/A |
12/31/2020 | 222 | 14 | 12 | 18 | N/A |
9/30/2020 | 198 | -11 | 2 | 9 | N/A |
6/30/2020 | 201 | -16 | -13 | -4 | N/A |
3/31/2020 | 210 | -14 | -19 | -7 | N/A |
12/31/2019 | 205 | -14 | 5 | 16 | N/A |
9/30/2019 | 212 | 23 | -4 | 5 | N/A |
6/30/2019 | 203 | 24 | 7 | 14 | N/A |
3/31/2019 | 204 | 27 | 9 | 13 | N/A |
12/31/2018 | 190 | 21 | -14 | -10 | N/A |
9/30/2018 | 174 | -2 | -11 | -8 | N/A |
6/30/2018 | 161 | -4 | -11 | -6 | N/A |
3/31/2018 | 141 | -10 | -17 | -13 | N/A |
12/31/2017 | 133 | -11 | -9 | -4 | N/A |
9/30/2017 | 118 | -16 | -17 | -12 | N/A |
6/30/2017 | 108 | -23 | -40 | -36 | N/A |
3/31/2017 | 90 | -28 | -43 | -37 | N/A |
12/31/2016 | 83 | -31 | -49 | -45 | N/A |
9/30/2016 | 74 | -33 | -49 | -40 | N/A |
6/30/2016 | 70 | -32 | -40 | -31 | N/A |
3/31/2016 | 73 | -27 | N/A | -27 | N/A |
12/31/2015 | 73 | -21 | N/A | -23 | N/A |
9/30/2015 | 73 | -20 | N/A | -19 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CRADBS's forecast earnings growth (49% per year) is above the savings rate (0.9%).
Earnings vs Market: CRADBS's earnings (49% per year) are forecast to grow faster than the UK market (10.3% per year).
High Growth Earnings: CRADBS's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: CRADBS's revenue (15.9% per year) is forecast to grow faster than the UK market (4% per year).
High Growth Revenue: CRADBS's revenue (15.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CRADBS's Return on Equity is forecast to be high in 3 years time (23%)